基因型分层辅助德克萨米他用于HIV阴性成年人的结核性脑膜炎:一种随机对照的第三期试验
Joseph Donovan1,2,3, Nguyen Duc Bang4, Huu Khanh Trinh Dong5,6
1Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam. jdonovan@oucru.org.
Nature medicine
|January 15, 2026
概括
在大多数具有特定基因类型的结核性脑膜炎患者中,德克萨米他与安慰剂相比没有显著的益处. 为了在结核性脑膜炎中获得更好的抗炎疗法,需要进一步的研究.
科学领域:
- 神经科学是一个神经科学.
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 像德克萨米他这样的辅助皮质类固醇用于结核性脑膜炎 (TBM) 治疗.
- 它们的生存益处是适度的,并且有所变化,可能受到Leukotriene A4酸酶 (LTA4H) 基因型的影响.
- 在TT基因型中看到了益处,但在CC和CT基因型中不确定.
研究的目的:
- 为了评估安慰剂是否与TBM和CC/CT LTA4H基因型的HIV阴性成年人中非劣或优于德萨.
- 根据LTA4H基因型,评估德克萨米松在TBM患者的安全性和有效性.
主要方法:
- 第三阶段,安慰剂对照试验涉及613名HIV阴性越南成年人TBM (CC/CT基因型).
- 参与者接受了6-8周的德克萨米他或安慰剂.
- TT基因型参与者接受了开放标签的德克萨米他 (89个人).
主要成果:
- 在CC/CT基因型中,主要终点 (死亡/神经事件) 发生在35.4% (德甲) 和35.7% (安慰剂) (HR 0.99) 的患者中.
- 没有确定安慰剂的非劣势性;德甲的益处在各个子组中并不显著.
- 在TT基因型参与者 (31.5%) 的结果与CC/CT基因型相似;德甲是安全的.
结论:
- 在CC/CT基因型TBM患者中,甲没有证明与安慰剂的非劣势或优势.
- 这种药物是安全的,但其适度和异质的益处突出了需要更好的抗炎症策略.
- 进一步了解TBM病理生理学对于开发更有针对性的疗法至关重要.
更多相关视频
03:47A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
Published on: October 25, 2024
607
11:34A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes
Published on: April 11, 2025
793
相关概念视频
01:29Pulmonary Tuberculosis I
838
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
838
01:26Pulmonary Tuberculosis IV
478
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
478
01:31Pulmonary Tuberculosis III
937
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
937
01:28Pulmonary Tuberculosis II
1.4K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.4K
01:28Pulmonary Tuberculosis V
540
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
540
01:01Dosage Regimen: Fixed Dose
2.3K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
2.3K